10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal Serge Saxonov DIRECTOR ELECTIONS ISSUER 146869 0 For 146869 FOR 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal Benjamin J. Hindson DIRECTOR ELECTIONS ISSUER 146869 0 For 146869 FOR 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualification or removal John R. Stuelpnagel DIRECTOR ELECTIONS ISSUER 146869 0 For 146869 FOR 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026; AUDIT-RELATED ISSUER 146869 0 For 146869 FOR 10X GENOMICS, INC. 88025U109 US88025U1097 06/04/2026 A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; SECTION 14A SAY-ON-PAY VOTES ISSUER 146869 0 For 146869 FOR ABSCI CORPORATION 00091E109 US00091E1091 06/04/2026 The election of the Class II directors nominated by the Board of Directors and named in the Proxy Statement to hold office for a three-year term expiring at our 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified. Prof Sir Menelas Pangalos, Ph.D. DIRECTOR ELECTIONS ISSUER 1905615 0 For 1905615 FOR ABSCI CORPORATION 00091E109 US00091E1091 06/04/2026 The election of the Class II directors nominated by the Board of Directors and named in the Proxy Statement to hold office for a three-year term expiring at our 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified. Daniel Rabinovitsj DIRECTOR ELECTIONS ISSUER 1905615 0 For 1905615 FOR ABSCI CORPORATION 00091E109 US00091E1091 06/04/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm to audit our financial statements for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1905615 0 For 1905615 FOR ARCHER AVIATION INC. 03945R102 US03945R1023 06/26/2026 Election of Director: 1. Barbara Pilarski DIRECTOR ELECTIONS ISSUER 366631 0 For 366631 FOR ARCHER AVIATION INC. 03945R102 US03945R1023 06/26/2026 Election of Director: 2. Maria Pinelli DIRECTOR ELECTIONS ISSUER 366631 0 For 366631 FOR ARCHER AVIATION INC. 03945R102 US03945R1023 06/26/2026 Approval of the redomestication of the Company from Delaware to Texas by conversion. CAPITAL STRUCTURE CORPORATE GOVERNANCE ISSUER 366631 0 For 366631 FOR ARCHER AVIATION INC. 03945R102 US03945R1023 06/26/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 366631 0 For 366631 FOR ARCHER AVIATION INC. 03945R102 US03945R1023 06/26/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 366631 0 For 366631 FOR BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Election of the following nominees as Class III directors for three- year terms ending at our Annual Meeting of Stockholders to be held in 2029. John Evans DIRECTOR ELECTIONS ISSUER 337310 0 For 337310 FOR BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Election of the following nominees as Class III directors for three- year terms ending at our Annual Meeting of Stockholders to be held in 2029. John Maraganore, Ph.D. DIRECTOR ELECTIONS ISSUER 337310 0 For 337310 FOR BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Election of the following nominees as Class III directors for three- year terms ending at our Annual Meeting of Stockholders to be held in 2029. Christi Shaw DIRECTOR ELECTIONS ISSUER 337310 0 For 337310 FOR BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 337310 0 For 337310 FOR BEAM THERAPEUTICS INC. 07373V105 US07373V1052 06/03/2026 Approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 337310 0 For 337310 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 Election of Director: 1. Thomas Lee DIRECTOR ELECTIONS ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 Election of Director: 2. Chi Tsang DIRECTOR ELECTIONS ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 Election of Director: 3. Michael Maloney DIRECTOR ELECTIONS ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 Election of Director: 4. Lori Love DIRECTOR ELECTIONS ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 Election of Director: 5. David Sharbutt DIRECTOR ELECTIONS ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 Election of Director: 6. Jason Edgeworth DIRECTOR ELECTIONS ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 Election of Director: 7. Olivia Howe DIRECTOR ELECTIONS ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 Election of Director: 8. Robert Sechan DIRECTOR ELECTIONS ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 To approve the charter amendment to increase the number of authorized shares of Common Stock. CAPITAL STRUCTURE ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 To approve the 2025 Omnibus Incentive Plan. COMPENSATION ISSUER 44079 0 For 44079 FOR BITMINE IMMERSION TECHNOLOGIES, INC. 09175A206 US09175A2069 01/15/2026 To approve, on a non-binding advisory basis, the special, performance-based compensation arrangement for the executive chairman. OTHER Approve/Amend Employment Agreements ISSUER 44079 0 For 44079 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 1. Brian Armstrong DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 2. Marc L. Andreessen DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 3. Christa Davies DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 4. Frederick E. Ehrsam III DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 5. Kelly A. Kramer DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 6. Chris Lehane DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 7. Tobias Lutke DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 8. Gokul Rajaram DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Election of Director: 9. Fred Wilson DIRECTOR ELECTIONS ISSUER 13344 0 For 13344 FOR COINBASE GLOBAL, INC. 19260Q107 US19260Q1076 06/16/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 13344 0 For 13344 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the Swiss management report, the consolidated financial statements and the statutory financial statements of the Company for the year ended December 31, 2025. OTHER Accept Consolidated Financial Statements and Statutory Reports ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the appropriation of financial results. CAPITAL STRUCTURE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Discharge of the members of the Board of Directors and the Executive Committee. CORPORATE GOVERNANCE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Samarth Kulkarni, Ph.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Ali Behbahani, M.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Maria Fardis, Ph.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. H. Edward Fleming, Jr., M.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Simeon J. George, M.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. John T. Greene DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Katherine A. High, M.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Sandesh Mahatme, LL.M. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Briggs W. Morrison, M.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Christian Rommel, Ph.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members to the Board of Directors and the Chairman. Douglas A. Treco, Ph.D. DIRECTOR ELECTIONS ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members of the Compensation Committee - Ali Behbahani, M.D. CORPORATE GOVERNANCE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members of the Compensation Committee - H. Edward Fleming, Jr., M.D. CORPORATE GOVERNANCE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members of the Compensation Committee - John T. Greene CORPORATE GOVERNANCE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the members of the Compensation Committee - Briggs W. Morrison, M.D. CORPORATE GOVERNANCE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum non- performance-related compensation for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. COMPENSATION ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. COMPENSATION ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum non- performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027. COMPENSATION ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026. COMPENSATION ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders. COMPENSATION ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the compensation for the Board of Directors and the Executive Committee and non-binding advisory vote on the 2025 Compensation Report - Non-binding advisory vote on the 2025 Compensation Report. COMPENSATION ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. SECTION 14A SAY-ON-PAY VOTES ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of an increase to the Company's capital band. CAPITAL STRUCTURE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of an increase to the conditional share capital for the conversion of bonds and similar debt instruments. CAPITAL STRUCTURE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. COMPENSATION ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the independent voting rights representative. CORPORATE GOVERNANCE ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Re-election of the auditors. AUDIT-RELATED ISSUER 171926 0 For 171926 FOR CRISPR THERAPEUTICS AG H17182108 CH0334081137 06/04/2026 Transact any other business that may properly come before the 2026 Annual General Meeting or any adjournment or postponement thereof. OTHER Other Business ISSUER 171926 0 For 171926 FOR INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Muna Bhanji, R.Ph. DIRECTOR ELECTIONS ISSUER 235077 0 For 235077 FOR INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Brian Goff DIRECTOR ELECTIONS ISSUER 235077 0 For 235077 FOR INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Election of three class I directors to our board of directors, each to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Jesse Goodman, M.D., M.P.H. DIRECTOR ELECTIONS ISSUER 235077 0 For 235077 FOR INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 235077 0 For 235077 FOR INTELLIA THERAPEUTICS, INC. 45826J105 US45826J1051 06/09/2026 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 235077 0 For 235077 FOR KODIAK AI, INC. 500081104 US5000811043 06/11/2026 Election of Directors Don Burnette DIRECTOR ELECTIONS ISSUER 110737 0 For 110737 FOR KODIAK AI, INC. 500081104 US5000811043 06/11/2026 Election of Directors Kristin Sverchek DIRECTOR ELECTIONS ISSUER 110737 0 For 110737 FOR KODIAK AI, INC. 500081104 US5000811043 06/11/2026 Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 110737 0 For 110737 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Directors William Ericson DIRECTOR ELECTIONS ISSUER 560804 0 For 560804 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Directors Chris Gibson, Ph.D. DIRECTOR ELECTIONS ISSUER 560804 0 For 560804 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Directors Christian O. Henry DIRECTOR ELECTIONS ISSUER 560804 0 For 560804 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Directors John F. Mulligan, Ph.D. DIRECTOR ELECTIONS ISSUER 560804 0 For 560804 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Directors Kathy Ordonez DIRECTOR ELECTIONS ISSUER 560804 0 For 560804 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 Election of Directors Christopher M. Smith DIRECTOR ELECTIONS ISSUER 560804 0 For 560804 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2026. AUDIT-RELATED ISSUER 560804 0 For 560804 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 To approve, on an advisory basis, the compensation of our named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 560804 0 For 560804 FOR PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 69404D108 US69404D1081 06/03/2026 To approve the amendment of our 2020 Equity Incentive Plan. COMPENSATION ISSUER 560804 0 For 560804 FOR PRIME MEDICINE, INC. 74168J101 US74168J1016 06/05/2026 Election of Director: 1. Michael Kelly DIRECTOR ELECTIONS ISSUER 1357869 0 For 1357869 FOR PRIME MEDICINE, INC. 74168J101 US74168J1016 06/05/2026 Election of Director: 2. David Schenkein, M.D. DIRECTOR ELECTIONS ISSUER 1357869 0 For 1357869 FOR PRIME MEDICINE, INC. 74168J101 US74168J1016 06/05/2026 To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 1357869 0 For 1357869 FOR RECURSION PHARMACEUTICALS, INC. 75629V104 US75629V1044 06/17/2026 Election of Director: 1. Najat Khan, Ph.D. DIRECTOR ELECTIONS ISSUER 620765 0 For 620765 FOR RECURSION PHARMACEUTICALS, INC. 75629V104 US75629V1044 06/17/2026 Election of Director: 2. Franziska Michor, Ph.D. DIRECTOR ELECTIONS ISSUER 620765 0 For 620765 FOR RECURSION PHARMACEUTICALS, INC. 75629V104 US75629V1044 06/17/2026 Advisory vote to approve executive compensation as disclosed in the 2026 Proxy Statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 620765 0 For 620765 FOR RECURSION PHARMACEUTICALS, INC. 75629V104 US75629V1044 06/17/2026 Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 620765 0 For 620765 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Vladimir Tenev DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Baiju Bhatt DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. John Hegeman DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Paula Loop DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Meyer Malka DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Christopher Payne DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Jonathan Rubinstein DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Susan Segal DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Dara Treseder DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To elect to the Board of Directors the ten director nominees named in the proxy statement. Robert Zoellick DIRECTOR ELECTIONS ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To approve, on an advisory basis, the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 51761 0 For 51761 FOR ROBINHOOD MARKETS, INC. 770700102 US7707001027 06/02/2026 To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 51761 0 For 51761 FOR ROBLOX CORPORATION 771049103 US7710491033 05/28/2026 Election of Director: 1. David Baszucki DIRECTOR ELECTIONS ISSUER 36535 0 For 36535 FOR ROBLOX CORPORATION 771049103 US7710491033 05/28/2026 Election of Director: 2. Gregory Baszucki DIRECTOR ELECTIONS ISSUER 36535 0 For 36535 FOR ROBLOX CORPORATION 771049103 US7710491033 05/28/2026 Election of Director: 3. Dennis Durkin DIRECTOR ELECTIONS ISSUER 36535 0 For 36535 FOR ROBLOX CORPORATION 771049103 US7710491033 05/28/2026 Advisory Vote on the Compensation of our Named Executive Officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 36535 0 For 36535 FOR ROBLOX CORPORATION 771049103 US7710491033 05/28/2026 Ratification of Independent Registered Public Accounting Firm. AUDIT-RELATED ISSUER 36535 0 For 36535 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Tobias Lutke DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Joseph Natale DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Lulu Cheng Meservey DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Jeanne DeWitt Grosser DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: David Heinemeier Hansson DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Jeremy Levine DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Prashanth Mahendra-Rajah DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Kevin Scott DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Toby Shannan DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Election of Director: Fidji Simo DIRECTOR ELECTIONS ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Auditor Proposal Resolution approving the reappointment of PricewaterhouseCoopers LLP as auditors of Shopify Inc. and authorizing the Board of Directors to fix their remuneration. AUDIT-RELATED ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Non-binding Advisory Vote on Executive Compensation Non- binding advisory vote that the shareholders accept Shopify Inc.'s approach to executive compensation as disclosed in the Management Information Circular for the Meeting. SECTION 14A SAY-ON-PAY VOTES ISSUER 19796 0 For 19796 FOR SHOPIFY INC. 82509L107 CA82509L1076 06/16/2026 Shareholder Proposal Vote on the shareholder proposal, as disclosed in the Management Information Circular for the Meeting. OTHER SOCIAL ISSUES SECURITY HOLDER 19796 0 Against 19796 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 1. Eric Lefkofsky DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 2. Peter J. Barris DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 3. Eric D. Belcher DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 4. Jennifer A. Doudna DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 5. David R. Epstein DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 6. Wayne A.I. Frederick MD DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 7. Scott Gottlieb, M.D. DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 8. Theodore J. Leonsis DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 Election of Director: 9. Nadja West, M.D. DIRECTOR ELECTIONS ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 To ratify the appointment by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026. AUDIT-RELATED ISSUER 85690 0 For 85690 FOR TEMPUS AI, INC. 88023B103 US88023B1035 05/21/2026 To consider a non-binding advisory vote on the frequency of future stockholder votes to approve the compensation of the Company's named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 85690 0 1 Year 85690 AGAINST TESLA, INC. 88160R101 US88160R1014 11/06/2025 A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified. Ira Ehrenpreis DIRECTOR ELECTIONS ISSUER 7913 0 For 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified. Joe Gebbia DIRECTOR ELECTIONS ISSUER 7913 0 For 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A Tesla proposal to elect three Class III directors to serve for a term of three years, or until their respective successors are duly elected and qualified. Kathleen Wilson-Thompson DIRECTOR ELECTIONS ISSUER 7913 0 For 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A Tesla proposal for a non-binding advisory vote approving 2024 executive compensation. SECTION 14A SAY-ON-PAY VOTES ISSUER 7913 0 For 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A Tesla proposal for approval of the A&R 2019 Equity Incentive Plan. COMPENSATION ISSUER 7913 0 For 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A Tesla proposal for approval of the 2025 CEO Performance Award. CAPITAL STRUCTURE COMPENSATION ISSUER 7913 0 For 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A Tesla proposal for the ratification of the appointment of PricewaterhouseCoopers LLP as Tesla's independent registered public accounting firm for the fiscal year ending December 31, 2025. AUDIT-RELATED ISSUER 7913 0 For 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A Tesla proposal for adoption of amendments to certificate of formation and bylaws to eliminate applicable supermajority voting requirements. CORPORATE GOVERNANCE ISSUER 7913 0 For 7913 NONE TESLA, INC. 88160R101 US88160R1014 11/06/2025 A shareholder proposal regarding Board authorization of an investment in xAl. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 7913 0 Against 7913 NONE TESLA, INC. 88160R101 US88160R1014 11/06/2025 A shareholder proposal regarding adopting targets and reporting on metrics to assess the feasibility of integrating sustainability metrics into senior executive compensation plans. COMPENSATION OTHER SOCIAL ISSUES SECURITY HOLDER 7913 0 Against 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A shareholder proposal requesting a child labor audit. HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE SECURITY HOLDER 7913 0 Against 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A shareholder proposal to amend the bylaws to repeal 3% derivative suit ownership threshold. CORPORATE GOVERNANCE SECURITY HOLDER 7913 0 Against 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A shareholder proposal to amend Article X of the bylaws. CORPORATE GOVERNANCE SECURITY HOLDER 7913 0 Against 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A shareholder proposal to elect each director annually. SHAREHOLDER RIGHTS AND DEFENSES SECURITY HOLDER 7913 0 Against 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A shareholder proposal regarding proposal that won 54% support at 2024 Tesla annual meeting. SHAREHOLDER RIGHTS AND DEFENSES CORPORATE GOVERNANCE SECURITY HOLDER 7913 0 Against 7913 FOR TESLA, INC. 88160R101 US88160R1014 11/06/2025 A shareholder proposal to seek shareholder approval before adopting an amendment to the bylaws pursuant to Section 21.373 of the TBOC. CORPORATE GOVERNANCE SECURITY HOLDER 7913 0 Against 7913 FOR TWIST BIOSCIENCE CORPORATION 90184D100 US90184D1000 02/05/2026 Election of Director: 1. Keith Crandell DIRECTOR ELECTIONS ISSUER 68679 0 For 68679 FOR TWIST BIOSCIENCE CORPORATION 90184D100 US90184D1000 02/05/2026 Election of Director: 2. Jan Johannessen DIRECTOR ELECTIONS ISSUER 68679 0 For 68679 FOR TWIST BIOSCIENCE CORPORATION 90184D100 US90184D1000 02/05/2026 Election of Director: 3. Trynka Shineman Blake DIRECTOR ELECTIONS ISSUER 68679 0 For 68679 FOR TWIST BIOSCIENCE CORPORATION 90184D100 US90184D1000 02/05/2026 To adopt, on an advisory basis, a resolution approving the compensation of the Company's Named Executive Officers, as described in the Proxy Statement under ''Executive Compensation.'' SECTION 14A SAY-ON-PAY VOTES ISSUER 68679 0 For 68679 FOR TWIST BIOSCIENCE CORPORATION 90184D100 US90184D1000 02/05/2026 To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2026. AUDIT-RELATED ISSUER 68679 0 For 68679 FOR